We may crash today on the worthless PR. Great job managements. Transferring the technology for FREE confirms its worthless? The initial step of the collaboration includes the execution of a Master Supply Agreement (“MSA”) providing for Cenexi to provide aseptic fill and finish services for lenzilumab for the next five years.
Under the terms of the agreement, Humanigen will transfer the technology and knowledge to Cenexi to allow them to establish drug product processes utilizing their state-of-the-art high speed filling line at their Herouville-Saint-Clair facility in Normandy. For FREE. No $ for HGEN’s ‘technology of its ‘super drug’
News 
Market Data 
Discover 
